|
|
???tair.name??? >
???browser.page.title.author???
|
"yang sheng shun"???jsp.browse.items-by-author.description???
Showing items 1-50 of 66 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2022-04-14T00:51:40Z |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
|
Yang, Sheng-Shun; Kao, Wei-Yu; Peng, Cheng-Yuan; Liu, Chen-Hua; Shih, Yu-Lueng; Lin, Chin-Lin; MENG-KUN TSAI; Lee, Chih-Yuan; Chang, Chun-Chao; Wu, Jo-Hsuan; Liu, Chun-Jen; Su, Tung-Hung; Tseng, Tai-Chung; Chen, Pei-Jer; Kao, Jia-Horng |
| 臺大學術典藏 |
2022-03-14T23:45:21Z |
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals
|
Chen, Yen Chun; Chang, Te Sheng; CHIEN-HUNG CHEN; Cheng, Pin Nan; Lo, Ching Chu; Mo, Lein Ray; CHUN-TING CHEN; Huang, Chung Feng; Kuo, Hsing Tao; Huang, Yi Hsiang; Tai, Chi Ming; Peng, Cheng Yuan; Bair, Ming Jong; Yeh, Ming Lun; Lin, Chih Lang; Lin, Chun Yen; Lee, Pei Lun; Chong, Lee Won; Hung, Chao Hung; Huang, Jee Fu; Yang, Chi Chieh; Hu, Jui Ting; Lin, Chih Wen; CHIA-CHI WANG; Su, Wei Wen; Hsieh, Tsai Yuan; Lin, Chih Lin; Tsai, Wei Lun; Lee, Tzong Hsi; Chen, Guei Ying; Wang, Szu Jen; Chang, Chun Chao; Yang, Sheng Shun; Wu, Wen Chih; Huang, Chia Sheng; Hsiung, Chou Kwok; Kao, Chien Neng; Tsai, Pei Chien; CHEN-HUA LIU; Lee, Mei Hsuan; Dai, Chia Yen; JIA-HORNG KAO; Chuang, Wan Long; Lin, Han Chieh; Chen, Chi Yi; Tseng, Kuo Chih; Yu, Ming Lung |
| 臺大學術典藏 |
2022-02-14T23:55:38Z |
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan
|
Lo, Ching Chu; Huang, Chung Feng; Cheng, Pin Nan; Tseng, Kuo Chih; Chen, Chi Yi; Kuo, Hsing Tao; Huang, Yi Hsiang; Tai, Chi Ming; Peng, Cheng Yuan; Bair, Ming Jong; CHIEN-HUNG CHEN; Yeh, Ming Lun; Lin, Chih Lang; Lin, Chun Yen; Lee, Pei Lun; Chong, Lee Won; Hung, Chao Hung; Chang, Te Sheng; Huang, Jee Fu; Yang, Chi Chieh; Hu, Jui Ting; Lin, Chih Wen; CHUN-TING CHEN; CHIA-CHI WANG; Su, Wei Wen; Hsieh, Tsai Yuan; Lin, Chih Lin; Tsai, Wei Lun; Lee, Tzong Hsi; Chen, Guei Ying; Wang, Szu Jen; Chang, Chun Chao; Mo, Lein Ray; Yang, Sheng Shun; Wu, Wen Chih; Huang, Chia Sheng; Hsiung, Chou Kwok; Kao, Chien Neng; Tsai, Pei Chien; CHEN-HUA LIU; Lee, Mei Hsuan; CHUN-JEN LIU; Dai, Chia Yen; Chuang, Wan Long; Lin, Han Chieh; JIA-HORNG KAO; Yu, Ming Lung |
| 臺大學術典藏 |
2022-01-15T00:07:58Z |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang, Chung Feng; Kuo, Hsing Tao; Chang, Te Sheng; Lo, Ching Chu; Hung, Chao Hung; Huang, Chien Wei; Chong, Lee Won; Cheng, Pin Nan; Yeh, Ming Lun; Peng, Cheng Yuan; Cheng, Chien Yu; Huang, Jee Fu; Bair, Ming Jong; Lin, Chih Lang; Yang, Chi Chieh; Wang, Szu Jen; Hsieh, Tsai Yuan; Lee, Tzong Hsi; Lee, Pei Lun; Wu, Wen Chih; Lin, Chih Lin; Su, Wei Wen; Yang, Sheng Shun; CHIA-CHI WANG; Hu, Jui Ting; Mo, Lein Ray; CHUN-TING CHEN; Huang, Yi Hsiang; Chang, Chun Chao; Huang, Chia Sheng; Chen, Guei Ying; Kao, Chien Neng; Tai, Chi Ming; CHUN-JEN LIU; Lee, Mei Hsuan; Tsai, Pei Chien; Dai, Chia Yen; JIA-HORNG KAO; Lin, Han Chieh; Chuang, Wang Long; Chen, Chi Yi; Tseng, Kuo Chih; Yu, Ming Lung |
| 臺大學術典藏 |
2022-01-15T00:07:58Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, Pin Nan; Mo, Lein Ray; CHUN-TING CHEN; Chen, Chi Yi; Huang, Chung Feng; Kuo, Hsing Tao; Lo, Ching Chu; Tseng, Kuo Chih; Huang, Yi Hsiang; Tai, Chi Ming; Peng, Cheng Yuan; Bair, Ming Jong; CHIEN-HUNG CHEN; Yeh, Ming Lun; Lin, Chih Lang; Lin, Chun Yen; Lee, Pei Lun; Chong, Lee Won; Hung, Chao Hung; Chang, Te Sheng; Huang, Jee Fu; Yang, Chi Chieh; Hu, Jui Ting; Lin, Chih Wen; CHIA-CHI WANG; Su, Wei Wen; Hsieh, Tsai Yuan; Lin, Chih Lin; Tsai, Wei Lun; Lee, Tzong Hsi; Chen, Guei Ying; Wang, Szu Jen; Chang, Chun Chao; Yang, Sheng Shun; Wu, Wen Chih; Huang, Chia Sheng; Chou, Kwok Hsiung; Kao, Chien Neng; Tsai, Pei Chien; CHEN-HUA LIU; Lee, Mei Hsuan; Cheng, Chien Yu; Tsai, Ming Chang; CHUN-JEN LIU; Dai, Chia Yen; Lin, Han Chieh; JIA-HORNG KAO; Chuang, Wan Long; Yu, Ming Lung |
| 臺大學術典藏 |
2021-12-14T23:12:16Z |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang, Chung Feng; Tseng, Kuo Chih; Cheng, Pin Nan; Hung, Chao Hung; Lo, Ching Chu; Peng, Cheng Yuan; Bair, Ming Jong; Yeh, Ming Lun; CHIEN-HUNG CHEN; Lee, Pei Lun; Lin, Chun Yen; Kuo, Hsing Tao; CHUN-TING CHEN; Yang, Chi Chieh; Huang, Jee Fu; Tai, Chi Ming; Hu, Jui Ting; Lin, Chih Lang; Su, Wei Wen; Tsai, Wei Lun; Huang, Yi Hsiang; Cheng, Chien Yu; Lin, Chih Lin; CHIA-CHI WANG; Yang, Sheng Shun; Mo, Lein Ray; Chen, Guei Ying; Chang, Chun Chao; Wang, Szu Jen; Huang, Chia Sheng; Hsieh, Tsai Yuan; Lin, Chih Wen; Lee, Tzong Hsi; Chong, Lee Won; Huang, Chien Wei; Chang, Shiuh Nan; Tsai, Ming Chang; Hsu, Shih Jer; JIA-HORNG KAO; CHUN-JEN LIU; CHEN-HUA LIU; Lin, Han Chieh; Lee, Mei Hsuan; Tsai, Pei Chien; Dai, Chia Yen; Chuang, Wan Long; Chen, Chi Yi; Yu, Ming Lung |
| 臺大學術典藏 |
2021-12-14T23:12:15Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
CHEN-HUA LIU; Chen, Chi Yi; Su, Wei Wen; CHUN-JEN LIU; Lo, Ching Chu; Huang, Ke Jhang; Chen, Jyh Jou; Tseng, Kuo Chih; Chang, Chi Yang; Peng, Cheng Yuan; Shih, Yu Lueng; Huang, Chia Sheng; Kao, Wei Yu; Yang, Sheng Shun; Tsai, Ming Chang; Wu, Jo Hsuan; Chen, Po Yueh; Su, Pei Yuan; Hwang, Jow Jyh; Fang, Yu Jen; Lee, Pei Lun; Tseng, Chi Wei; Lee, Fu Jen; Lai, Hsueh Chou; Hsieh, Tsai Yuan; Chang, Chun Chao; Chang, Chung Hsin; Huang, Yi Jie; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-12-14T23:11:55Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
CHUN-MING HONG; Lin, You Yu; CHUN-JEN LIU; Lai, Ya Yun; Shiou-Hwei Yeh; HUNG-CHIH YANG; JIA-HORNG KAO; Hsu, Shih Jer; Huang, Yi Hsiang; Yang, Sheng Shun; Kuo, Hsing Tao; Cheng, Pin Nan; Yu, Ming Lung; PEI-JER CHEN |
| 臺大學術典藏 |
2021-01-18T09:12:03Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
CHEN-HUA LIU; Chen, Chi Yi; Su, Wei Wen; Tseng, Kuo Chih; Lo, Ching Chu; CHUN-JEN LIU; Chen, Jyh Jou; Peng, Cheng Yuan; Shih, Yu Lueng; Yang, Sheng Shun; Huang, Chia Sheng; Huang, Ke Jhang; Chang, Chi Yang; Tsai, Ming Chang; Kao, Wei Yu; Fang, Yo Jen; Chen, Po Yueh; Su, Pei Yuan; Tseng, Chih Wei; Huang, Jow Jyh; Lee, Pei Lun; Lai, Hsueh Chou; Hsieh, Tsai Yuan; Chang, Chung Hsin; Huang, Yi Jie; Lee, Fu Jen; Chang, Chun Chao; Kao, Jia-Horng |
| 中山醫學大學 |
2019-11 |
Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status
|
Lee, Shou-Wu;Lee, Teng-Yu;Peng, Yen-Chun;Yang, Sheng-Shun;Yeh, Hong-Zen;Chang, Chi-Sen |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 中山醫學大學 |
2018-11 |
The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real world
|
Lee, Teng-Yu;Yang, Sheng-Shun |
| 臺大學術典藏 |
2018-09-10T15:35:05Z |
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun;Kao, Jia-Horng; Yang, Sheng-Shun; Yang, Sheng-Shun; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:22:34Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Huang, Chung-Feng; PEI-JER CHEN; Liu, Chun-Jen; Dai, Chia-Yen; CHEN-HUA LIU; DING-SHINN CHEN; Huang, Jee-Fu; Lin, Jou-Wei; TUNG-HUNG SU; JIA-HORNG KAO; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Wu, Cho-Kai; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Su, Mao-Yuan; Huang, Chung-Feng; PEI-JER CHEN; Lee, Jen-Kuang; Liu, Chun-Jen; Dai, Chia-Yen; Chiang, Fu-Tien; CHEN-HUA LIU; Hwang, Juey-Jen; Huang, Jee-Fu; DING-SHINN CHEN; Lin, Jiunn-Lee; TUNG-HUNG SU; Lin, Jou-Wei; JIA-HORNG KAO; Chen, Jin-Jer; Liang, Cheng-Chao; Yang, Sheng-Shun; Liu, Fu-Tong; Lin, Chih-Lin; Tsai, Chia-Ti; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; ??????; ?L?T??; ?????; ??Z??; ?d????; ???礯; ?????? |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
DING-SHINN CHEN; Hung, Peir-Haur; Tsai, Hung-Bin; JIA-HORNG KAO; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; TUNG-HUNG SU; Liu, Chen-Hua;Liu, Chun-Jen;Huang, Chung-Feng;Lin, Jou-Wei;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Lee, Chih-Yuan;Chen, Shih-I;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, C.-H. and Liu, C.-J. and Huang, C.-F. and Lin, J.-W. and Dai, C.-Y. and Liang, C.-C. and Huang, J.-F. and Hung, P.-H. and Tsai, H.-B. and Tsai, M.-K. and Lee, C.-Y. and Chen, S.-I. and Yang, S.-S. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Yu, M.-L. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;李志元;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; HUNG-CHIH YANG; Liu, Chen-Hua; Liu, Chun-Jen; MENG-KUN TSAI; Huang, Chung-Feng; CHUN-JEN LIU; PEI-JER CHEN; Lin, Jou-Wei; HUNG-BIN TSAI; Dai, Chia-Yen; Liang, Cheng-Chao; CHEN-HUA LIU; Huang, Jee-Fu |
| 臺大學術典藏 |
2018-09-10T15:18:40Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維; Hsu, Feng-Ming; Liu, Chen-Hua; YIH-LEONG CHANG; Cheng, Jason Chia-Hsien; Huang, Chung-Feng; ERIC YAO-YU CHUANG; Chang, Yih-Leong; JANG-MING LEE; Liu, Chun-Jen; Dai, Chia-Yen; Lee, Jang-Ming; Huang, Jee-Fu; Koong, Albert C.; Lin, Jou-Wei; Chuang, Eric Y.; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Chang, Yih-Leong;Lee, Jang-Ming;Koong, Albert C.;Chuang, Eric Y.; Hsu, F.-M. and Cheng, J.C.-H. and Chang, Y.-L. and Lee, J.-M. and Koong, A.C. and Chuang, E.Y.; 張逸良;成佳憲;李章銘;許峰銘; 成佳憲 |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun;Kao, Jia-Horng; JIA-HORNG KAO; Yang, Sheng-Shun; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T14:57:15Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, C.-J. and Chang, J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, Y.-J. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Yang, M.-D. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; Liu, Chun-Jen;Chang, Juliana;Lee, Po-Huang;Lin, Deng-Yn;Wu, Cheng-Chung;Jeng, Long-Bin;Lin, Yih-Jyh;Mok, King-Tong;Lee, Wei-Chen;Yeh, Hong-Zen;Ho, Ming-Chih;Yang, Sheng-Shun;Yang, Mei-Due;Yu, Ming-Chin;Hu, Rey-Heng;Peng, Cheng-Yuan;Lai, Kuan-Lang;Chang, Stanley Shi-Chung;Chen, Pei-Jer; 胡瑞恒;劉俊人;陳培哲;李伯皇;何明志; MING-CHIH HO; Liu, Chun-Jen; Chang, Juliana; CHUN-JEN LIU; Lee, Po-Huang; PEI-JER CHEN; REY-HENG HU; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
|
Dai, Chia-Yen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Chen, Shih-I;Lin, Jou-Wei;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, Chun-Jen; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; Liu, Chen-Hua; Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Huang, Chung-Feng; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:23:43Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; Liu, Chen-Hua; CHUN-JEN LIU; Liang, Cheng-Chao; Liang, Cheng-Chao; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; DING-SHINN CHEN; Tseng, Tai-Chung; TUNG-HUNG SU; Lin, Chih-Lin; Yang, Sheng-Shun; JIA-HORNG KAO; Su, Tung-Hung; Lin, Jou-Wei; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:23:42Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Chen, Jun-Herng; Lin, Jou-Wei; Lin, Jou-Wei; Hsu, Shih-Jer; Hsu, Shih-Jer; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Lin, Chih-Lin; Yang, Sheng-Shun; Yang, Sheng-Shun; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Hsu, Shih-Jer;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Hsu, S.-J., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; CHUN-JEN LIU; Liu, Chen-Hua; Liang, Cheng-Chao; PEI-JER CHEN; Liang, Cheng-Chao; Liu, Chun-Jen; Liu, Chun-Jen; CHEN-HUA LIU; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Lin, Chih-Lin; TUNG-HUNG SU |
| 臺大學術典藏 |
2018-09-10T09:14:11Z |
The binding affinity and molecular basis of the structure-binding relationship between urinary tamm-horsfall glycoprotein and tumor necrosis factor-α
|
Chang, Juliana; Li, Ko-Jen; Lee, Po-Huang; Siao, Sue-Cien; Siao, Sue-Cien; Chen, Yu-Hsuan; Chen, Yu-Hsuan; Lin, Deng-Yn; Wu, Tsai-Hung; Wu, Cheng-Chung; Wu, Tsai-Hung; Jeng, Long-Bin; Tsai, Chang-Youh; Tsai, Chang-Youh; Lin, Yih-Jyh; Yu, Chia-Li; Yu, Chia-Li; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志; Wu, C.-H. and Li, K.-J. and Siao, S.-C. and Chen, Y.-H. and Wu, T.-H. and Tsai, C.-Y. and Yu, C.-L.; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; Wu, Cheng-Han;Li, Ko-Jen;Siao, Sue-Cien;Chen, Yu-Hsuan;Wu, Tsai-Hung;Tsai, Chang-Youh;Yu, Chia-Li; 余家利;吳政翰; Liu, Chun-Jen; Wu, Cheng-Han; CHENG-HAN WU; Wu, Cheng-Han; Li, Ko-Jen |
| 臺大學術典藏 |
2018-09-10T07:26:51Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, C.-J. and Lee, P.-H. and Lin, D.-Y. and Wu, C.-C. and Jeng, L.-B. and Lin, P.-W. and Mok, K.-T. and Lee, W.-C. and Yeh, H.-Z. and Ho, M.-C. and Yang, S.-S. and Lee, C.-C. and Yu, M.-C. and Hu, R.-H. and Peng, C.-Y. and Lai, K.-L. and Chang, S.S.-C. and Chen, P.-J.; 劉俊人;李伯皇;胡瑞恆;吳誠中;鄭隆賓;林炳文;莫景棠;葉宏仁;何明志;楊勝舜;陳培哲; LIU, CHUN-JEN;LEE, PO-HUANG;HU, REY-HENG;WU, CHENG-CHUNG;JENG, LONG-BIN;LIN, PIN-WEN;MOK, KING-TONG;YEH, HONG-ZEN;HO, MING-CHIH;YANG, SHENG-SHUN;CHEN, PEI-JER; MING-CHIH HO; PO-HUANG LEE; CHUN-JEN LIU; PEI-JER CHEN; REY-HENG HU; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER |
| 臺大學術典藏 |
2018-09-10T05:02:40Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei, DJ;Hsu, HC;Lee, PH;Jeng, YM;Pu, YS;Chen, CN;Lee, YC;Chou, WC;Chang, CJ;Ni, YH;Chang, MH.; Tsuei, D.-J. and Hsu, H.-C. and Lee, P.-H. and Jeng, Y.-M. and Pu, Y.-S. and Chen, C.-N. and Lee, Y.-C. and Chou, W.-C. and Chang, C.-J. and Ni, Y.-H. and Chang, M.-H.; Liu, Chen-Hua; Tsuei, DJ; PO-HUANG LEE; Hsu, HC; Huang, Chung-Feng; MEI-HWEI CHANG; Lee, PH; Liu, Chun-Jen; CHIUNG-NIEN CHEN; YUNG-MING JENG; Dai, Chia-Yen; Jeng, YM; Yen-Hsuan Ni; Huang, Jee-Fu; Pu, YS; Chen, CN; Lin, Jou-Wei; YEONG-SHIAU PU; Lee, YC; Liang, Cheng-Chao; Chou, WC; Yang, Sheng-Shun; Lin, Chih-Lin; Chang, CJ; Su, Tung-Hung; Ni, YH; Yang, Hung-Chih; Chang, MH.; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 中山醫學大學 |
2018-01-01 |
The ultra-short virological dynamics in response to entecavir or lamivudine during chronic hepatitis B with spontaneous severe acute exacerbation
|
Lee, Teng-Yu;Chen, Chi-Yi;Lia, Hsueh-Chou;Hsu, Yu-Chung;Yang, Sheng-Shun |
| 中山醫學大學 |
2017-12 |
Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-up
|
Liao, Yi-Jun;Li, Yen-Chang;Lee, Shou-Wu;Wu, Chun-Ying;Yang, Sheng-Shun;Yeh, Hong-Zen;Chang, Chi-Sen;Lee, Teng-Yu |
| 中山醫學大學 |
2017-06 |
Oral Direct Acting Antivirals treatment failed to cure a patient with chronic hepatitis C due to shifts of viral genotype
|
Lee, Shou-Wu;Yang, Sheng-Shun;Lee, Teng-Yu;Yeh, Hong-Zen;Lu, I-Ta;Chang, Chi-Sen |
| 國立臺灣大學 |
2016 |
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
|
Wang, Chia-Chi; Lin, Chih-Lin; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Peng, Cheng-Yuan; Su, Tung-Hung; Yang, Sheng-Shun; Hsu, Yu-Chun; Chen, Tsung-Ming; Kao, Jia-Horng; 高嘉宏; 蘇東弘 |
| 國立臺灣大學 |
2016 |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Bair, Ming-Jong; Liang, Cheng-Chao; Lei, Yung-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2016 |
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
|
Chang, Mei-Hwei; You, San-Lin; Chen, Chien-Jen; Liu, Chun-Jen; Lai, Ming-Wei; Wu, Tzee-Chung; Wu, Shu-Fen; Lee, Chuan-Mo; Yang, Sheng-Shun; Chu, Heng-Cheng; Wang, Tsang-Eng; Chen, Bor-Wen; Chuang, Wan-Long; Soon, Maw-Soan; Lin, Ching-Yih; Chiou, Shu-Ti; Kuo, Hsu-Sung; Chen, Ding-Shinn; 陳定信; 張美惠; 劉俊人 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2015 |
Peginterferon plus weight-based ribavirin for treatment-naive hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naive Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立成功大學 |
2014-08-28 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 亞洲大學 |
2014-06 |
Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ
|
Ch, Shu-Chuan;Chang, Shu-Chuan;Sheng-Shun, Y;Yang, Sheng-Shun;Ch, Chiu-Chun;Chang, Chiu-Chun;Lin, Chun-Che;Lin, Chun-Che;Ch, Yueh-Chin;Chung, Yueh-Chin;李采娟* |
| 臺北醫學大學 |
2014 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study
|
Su, Tung-Hung;Hu, Tsung-Hui;Chen, Chi-Yi;Huang, Yi-Hsiang;Chuang, Wan-Long;Lin, Chun-Che;Wang, Chia-Chi;Su, Wei-Wen;Peng, Cheng-Yuan;Chien, Rong-Nan;Mo, Lein-Ray;Huang, Yi-Wen;Chen, Ming-Yao;Lin, Chih-Lin;Chen, Tsung-Ming;Wang, Horng-Yuan;Tseng, Kuo-Chih;Yang, Sheng-Shun;Hsu, Shih-Jer;Suk, Fat-Moon;Hu, Chi-Tan;Hsieh, Tsai-Yuan;Ming-jong, Bair;Liang, Cheng-Chao;Tseng, Tai-Chung;Chen, Chi-Ling;Kao, Jia-Horng |
| 國立臺灣大學 |
2014 |
Inosine Triphosphatase and Interleukin 28B Genetic Variants to Predict Sustained Virologic Response in Hemodialysis Patients with Hepatitis C Virus Genotype 1 or 2 Infection who Received Peginterferon alfa-2a plus Low-Dose Ribavirin: Data Analysis from HELPER-1 and HELPER-2 Trials
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2014 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志 |
| 國立臺灣大學 |
2014 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Pegylated Interferon-alpha 2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2013 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Tseng, Tai-Chung; Lin, Chih-Lin; Yang, Sheng-Shun; Su, Tung-Hung; Hsu, Shih-Jer; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 徐士哲; 劉俊人; 陳培哲; 陳俊恒; 林昭維 |
| 國立臺灣大學 |
2012 |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Tseng, Tai-Chung; Lin, Chih-Lin; Yang, Sheng-Shun; Su, Tung-Hung; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳俊恒; 林昭維 |
| 國立臺灣大學 |
2011 |
Effect of Host and Viral Factors on Hepatitis B E Antigen-Positive Chronic Hepatitis B Patients Receiving Pegylated Interferon-Alpha-2a Therapy
|
曾岱宗; 余明隆; 劉俊人; 林志陵; 黃奕文; 許景盛; 劉振驊; 楊勝舜; 高嘉宏; 陳培哲; 陳定信; TSENG, TAI-CHUNG; YU, MING-LUNG; LIU, CHUN-JEN; LIN, CHIH-LIN; HUANG, YI-WEN; HSU, CHING-SHENG; LIU, CHEN-HUA; YANG, SHENG-SHUN; KAO, JIA-HORNG; CHEN, PEI-JER; CHEN, DING-SHINN |
| 國立成功大學 |
2009-12 |
Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas
|
Su, Wei-Wen; Chen, Chien-Hung; Lin, Hans Hsienhong; Yang, Sheng-Shun; Chang, Ting-Tsung; Cheng, Ken-Sheng; Wu, Jaw-Ching; Wu, Shun-Sheng; Lee, Chuan-Mo; Changchien, Chi-Sin; Chen, Chien-Jen; Sheu, Jin-Chuan; Chen, Ding-Shinn; Lu, Sheng-Nan |
| 國立成功大學 |
2009-05 |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, Chun-Jen; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Pin-Wen; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Lee, Ching-Chih; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
Showing items 1-50 of 66 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
